Coverage / MRK / Trade Card

MRK

Merck & Co Inc

OPPORTUNISTIC BUY 2026-08-01 Updated today USD 130.20 Healthcare - Drug Manufacturers - GeneralAWAIT ENTRY
51

Position levels

Currenttoday
USD 130.20
Buy <=wait / entry
USD 101.67
Trim >=take some off
USD 135.00
Thesis breakA final, non-appealable US patent ruling that materially shortens Keytruda's exc...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case51%62 / 10031.6
Bear case33%10 / 1003.3
Weighted conviction51 / 100 - OPPORTUNISTIC BUY

Top risks

  • Q1 2026 EPS beat of 13.51% (-$1.28 actual vs -$1.48 estimate)
  • Recent acquisition of Terns Pharma with $5.8B charge impacting earnings
  • Significant decline in Gardasil/Gardasil 9 sales in China, with no material increase expected in 2026
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.